OCU reports Somatoline for misleading advertising

A laboratory study by OCU, found that SOMATOLINE Cosmetic, a cosmetic product has hardly any effect despite promising, through its advertising, an intense and speedy effect as a localized fat reducer.

For this study, OCU has collaborated with 60 women, who used the cream for 14 days. Measurements were taken around the hip, waist and thighs in addition to an ultrasound scan to determine the reduction of subcutaneous fat.

The results have shown the limited effectiveness of the product. In the best of cases, proven reduction reaches only 0.9 cm, which is almost negligible when compared with the total measurement. Subcutaneous fat reduction is even less, barely 2 mm.

In contrast, the product’s advertising, far from reporting actual results, exaggerates the results, giving consumers a wrong idea about the effectiveness of the product. OCU has contacted the Department of Consumer Affairs for the Community of Madrid because we consider that the advertising of this product is misleading to consumers and is clearly untrue.